Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial

Nutrition

Volumn 32, Issue 3, 2016, Pages 315-320

  Akkasheh, Ghodarz ^a   Kashani Poor, Zahra ^a   Tajabadi Ebrahimi, Maryam ^b   Jafari, Parvaneh ^c   Akbari, Hossein ^a   Taghizadeh, Mohsen ^a   Memarzadeh, Mohammad Reza ^d   Asemi, Zatollah ^a   Esmaillzadeh, Ahmad ^e,f,g  

^a KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d Medicinal Plants Research Center of Barij   (Iran)

^e ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Depression; Glucose metabolism; Lipid profiles; Oxidative stress; Probiotics

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; GLUTATHIONE; HIGH SENSITIVITY C REACTIVE PROTEIN; INSULIN; LIPID; PROBIOTIC AGENT; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CHOLESTEROL; GLUCOSE BLOOD LEVEL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BACTERIAL STRAIN; BECK DEPRESSION INVENTORY; BIFIDOBACTERIUM BIFIDUM; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DIETARY INTAKE; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT OF BETA CELL FUNCTION; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LIPID ANALYSIS; MAJOR DEPRESSION; MALE; METABOLIC PARAMETERS; METABOLISM; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; BIFIDOBACTERIUM; BLOOD; DEPRESSIVE DISORDER, MAJOR; DIETARY SUPPLEMENT; DOUBLE BLIND PROCEDURE; MEDICAL RECORD; MIDDLE AGED; MOTOR ACTIVITY; OXIDATIVE STRESS; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; BIFIDOBACTERIUM; BIOMARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CHOLESTEROL; DEPRESSIVE DISORDER, MAJOR; DIET RECORDS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; GLUTATHIONE; HUMANS; INSULIN; INSULIN RESISTANCE; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; MALE; MIDDLE AGED; MOTOR ACTIVITY; OXIDATIVE STRESS; PROBIOTICS; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME; TRIGLYCERIDES; YOUNG ADULT;

EID: 84961202243     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2015.09.003     Document Type: Article

References (45)

1. Yamanishi K., Doe N., Sumida M., Watanabe Y., Yoshida M., Yamamoto H., et al. Hepatocyte nuclear factor 4 alpha is a key factor related to depression and physiological homeostasis in the mouse brain. PLoS One 2015, 10:e0119021.
2. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey replication. Arch Gen Psychiatry 2005, 62:593-602.
3. Chang C.C., Jou S.H., Lin T.T., Lai T.J., Liu C.S. Mitochondria DNA change and oxidative damage in clinically stable patients with major depressive disorder. PLoS One 2015, 10:e0125855.
4. Reus G.Z., Fries G.R., Stertz L., Badawy M., Passos I.C., Barichello T., et al. The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders. Neuroscience 2015, 300:141-154.
5. Yokoyama K., Yamada T., Mitani H., Yamada S., Pu S., Yamanashi T., et al. Relationship between hypothalamic-pituitary-adrenal axis dysregulation and insulin resistance in elderly patients with depression. Psychiatry Res 2015, 226:494-498.
6. Lapidus K.A., Gabbay V., Mao X., Johnson A., Murrough J.W., Mathew S.J., et al. In vivo H MRS study of potential associations between glutathione, oxidative stress and anhedonia in major depressive disorder. Neurosci Lett 2014, 569:74-79.
7. Kopp-Hoolihan L. Prophylactic and therapeutic uses of probiotics: a review. J Am Diet Assoc 2001, 101:229-238.
8. Broekaert I.J., Walker W.A. Probiotics and chronic disease. J Clin Gastroenterol 2006, 40:270-274.
9. Logan A.C., Katzman M. Major depressive disorder: probiotics may be an adjuvant therapy. Med Hypotheses 2005, 64:533-538.
10. Messaoudi M., Lalonde R., Violle N., Javelot H., Desor D., Nejdi A., et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr 2011, 105:755-764.
11. Mohammadi A.A., Jazayeri S., Khosravi-Darani K., Solati Z., Mohammadpour N., Asemi Z., et al. The effects of probiotics on mental health and hypothalamic-pituitary-adrenal axis: a randomized, double-blind, placebo-controlled trial in petrochemical workers. Nutr Neurosci 2015, [Epub ahead of print].
12. Chamari M., Djazayery A., Jalali M., Sadrzadeh Yeganeh H., Hosseini S., Heshmat R. The effect of daily consumption of probiotic and conventional yoghurt on some oxidative stress factors in plasma of young healthy women. ARYA Atheroscler J 2008, 4:175-179.
13. Rao A.V., Bested A.C., Beaulne T.M., Katzman M.A., Iorio C., Berardi J.M., et al. A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog 2009, 1:1-6.
14. Benton D., Williams C., Brown A. Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur J Clin Nutr 2007, 61:355-361.
15. Asemi Z., Zare Z., Shakeri H., Sabihi S.S., Esmaillzadeh A. Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes. Ann Nutr Metab 2013, 63:1-9.
16. Asemi Z., Jazayeri S., Najafi M., Samimi M., Mofid V., Shidfar F., et al. Effect of daily consumption of probiotic yogurt on oxidative stress in pregnant women: a randomized controlled clinical trial. Ann Nutr Metab 2012, 60:62-68.
17. Dickerson F.B., Stallings C., Origoni A., Katsafanas E., Savage C.L., Schweinfurth L.A., et al. Effect of probiotic supplementation on schizophrenia symptoms and association with gastrointestinal functioning: a randomized, placebo-controlled trial. Prim Care Companion CNS Disord 2014, 16.
18. Foster J.A., McVey Neufeld K.A. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci 2013, 36:305-312.
19. Yadav H., Lee J.H., Lloyd J., Walter P., Rane S.G. Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. J Biol Chem 2013, 288:25088-25097.
20. Desbonnet L., Garrett L., Clarke G., Bienenstock J., Dinan T.G. The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J Psychiatr Res 2008, 43:164-174.
21. Soccol C.R., de Souza Vandenberghe L.P., Spier M.R., Medeiros A.B., Yamaguishi C.T., Lindner J.D.D., et al. The potential of probiotics: a review. Food Technol Biotechnol 2010, 48:413-434.
22. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961, 4:561-571.
23. Pisprasert V., Ingram K.H., Lopez-Davila M.F., Munoz A.J., Garvey W.T. Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans. Diabetes Care 2013, 36:845-853.
24. Benzie I.F., Strain J.J. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 1996, 239:70-76.
25. Beutler E., Gelbart T. Plasma glutathione in health and in patients with malignant disease. J Lab Clin Med 1985, 105:581-584.
26. Li G., Mbuagbaw L., Samaan Z., Falavigna M., Zhang S., Adachi J.D., et al. Efficacy of vitamin D supplementation in depression in adults: a systematic review. J Clin Endocrinol Metab 2014, 99:757-767.
27. Martinac M., Pehar D., Karlovic D., Babic D., Marcinko D., Jakovljevic M. Metabolic syndrome, activity of the hypothalamic-pituitary-adrenal axis and inflammatory mediators in depressive disorder. Acta Clin Croat 2014, 53:55-71.
28. Saulnier D.M., Ringel Y., Heyman M.B., Foster J.A., Bercik P., Shulman R.J., et al. The intestinal microbiome, probiotics and prebiotics in neurogastroenterology. Gut Microbes 2013, 4:17-27.
29. Sherman P.M. Probiotics and lactose maldigestion. Can J Gastroenterol 2004, 18:81-82.
30. Ledochowski M., Widner B., Bair H., Probst T., Fuchs D. Fructose- and sorbitol-reduced diet improves mood and gastrointestinal disturbances in fructose malabsorbers. Scand J Gastroenterol 2000, 35:1048-1052.
31. Ledochowski M., Widner B., Propst-Braunsteiner T., Vogel W., Sperner-Unterweger B., Fuchs D. Fructose malabsorption is associated with decreased plasma tryptophan. Adv Exp Med Biol 1999, 467:73-78.
32. Firouzi S., Barakatun-Nisak M.Y., Ismail A., Majid H.A., Nor Azmi K. Role of probiotics in modulating glucose homeostasis: evidence from animal and human studies. Int J Food Sci Nutr 2013, 64:780-786.
33. Ejtahed H.S., Mohtadi-Nia J., Homayouni-Rad A., Niafar M., Asghari-Jafarabadi M., Mofid V., et al. Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. J Dairy Sci 2011, 94:3288-3294.
34. Tripolt N.J., Leber B., Blattl D., Eder M., Wonisch W., Scharnagl H., et al. Short communication: effect of supplementation with Lactobacillus casei Shirota on insulin sensitivity, beta-cell function, and markers of endothelial function and inflammation in subjects with metabolic syndrome-a pilot study. J Dairy Sci 2013, 96:89-95.
35. Ma X., Hua J., Li Z. Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells. J Hepatol 2008, 49:821-830.
36. Nakamura Y.K., Omaye S.T. Metabolic diseases and pro- and prebiotics: mechanistic insights. Nutr Metab (Lond) 2012, 9:60.
37. Zarrati M., Salehi E., Nourijelyani K., Mofid V., Zadeh M.J., Najafi F., et al. Effects of probiotic yogurt on fat distribution and gene expression of proinflammatory factors in peripheral blood mononuclear cells in overweight and obese people with or without weight-loss diet. J Am Coll Nutr 2014, 33:417-425.
38. Asemi Z., Jazayeri S., Najafi M., Samimi M., Mofid V., Shidfar F., et al. Effects of daily consumption of probiotic yoghurt on inflammatory factors in pregnant women: a randomized controlled trial. Pak J Biol Sci 2011, 14:476-482.
39. Alipour B., Homayouni-Rad A., Vaghef-Mehrabany E., Sharif S.K., Vaghef-Mehrabany L., Asghari-Jafarabadi M., et al. Effects of Lactobacillus casei supplementation on disease activity and inflammatory cytokines in rheumatoid arthritis patients: a randomized double-blind clinical trial. Int J Rheum Dis 2014, 17:519-527.
40. Shoaei T., Heidari-Beni M., Tehrani H.G., Feizi A., Esmaillzadeh A., Askari G. Effects of probiotic supplementation on pancreatic beta-cell function and C-reactive protein in women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. Int J Prev Med 2015, 6:27.
41. Ridker P.M., Hennekens C.H., Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342:836-843.
42. Sadrzadeh-Yeganeh H., Elmadfa I., Djazayery A., Jalali M., Heshmat R., Chamary M. The effects of probiotic and conventional yoghurt on lipid profile in women. Br J Nutr 2010, 103:1778-1783.
43. Hegazy S.K., El-Bedewy M.M. Effect of probiotics on pro-inflammatory cytokines and NF-kappaB activation in ulcerative colitis. World J Gastroenterol 2010, 16:4145-4151.
44. Asemi Z., Khorrami-Rad A., Alizadeh S.A., Shakeri H., Esmaillzadeh A. Effects of synbiotic food consumption on metabolic status of diabetic patients: a double-blind randomized cross-over controlled clinical trial. Clin Nutr 2014, 33:198-203.
45. Lutgendorff F., Trulsson L.M., van Minnen L.P., Rijkers G.T., Timmerman H.M., Franzen L.E., et al. Probiotics enhance pancreatic glutathione biosynthesis and reduce oxidative stress in experimental acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 2008, 295:G1111-G1121.